These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 558337)

  • 21. Analytical methodology and the interface with animal drug approval.
    Perez MK
    J Assoc Off Anal Chem; 1978 Sep; 61(5):1183-91. PubMed ID: 581494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Application of metabolic data to the evaluation of drugs. A report prepared by the committee on problems of drug safety of the drug research board, National Academy of Sciences-National Research Council.
    Clin Pharmacol Ther; 1969; 10(5):607-34. PubMed ID: 4980111
    [No Abstract]   [Full Text] [Related]  

  • 23. FDA and veterinary practice philosophy of drug use.
    Knobloch CP
    J Am Vet Med Assoc; 1980 Jul; 177(1):34,38. PubMed ID: 7429937
    [No Abstract]   [Full Text] [Related]  

  • 24. Educating veterinarians to prescribe and use drugs in a responsible manner.
    Jenkins WL
    J Am Vet Med Assoc; 1993 May; 202(10):1708-10;discussion 1713-7. PubMed ID: 8514590
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmacogenomics. Going from genome to pill.
    Service RF
    Science; 2005 Jun; 308(5730):1858-60. PubMed ID: 15976283
    [No Abstract]   [Full Text] [Related]  

  • 26. FDA new drug approvals in 2009.
    Wynn RL
    Gen Dent; 2010; 58(4):280-4. PubMed ID: 20591770
    [No Abstract]   [Full Text] [Related]  

  • 27. Comments on the AVMA drug Availability Committee Statement to FDA Commissioner Kennedy.
    Crawford LM
    J Am Vet Med Assoc; 1979 Apr; 174(8):854-6. PubMed ID: 500428
    [No Abstract]   [Full Text] [Related]  

  • 28. Pharmaceutical analysis: key to drug quality and control.
    Florey KG; Brewer GA
    Am Pharm; 1981 Aug; NS21(8):30-5. PubMed ID: 7270421
    [No Abstract]   [Full Text] [Related]  

  • 29. Drug therapy monitoring notes--untapped source of data.
    Riddiough MA
    Am J Hosp Pharm; 1978 Mar; 35(3):241, 243. PubMed ID: 626202
    [No Abstract]   [Full Text] [Related]  

  • 30. When to conduct a renal impairment study during drug development: US Food and Drug Administration perspective.
    Huang SM; Temple R; Xiao S; Zhang L; Lesko LJ
    Clin Pharmacol Ther; 2009 Nov; 86(5):475-9. PubMed ID: 19844224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Summary comments on drug metabolism and residue chemistry requirements for the use of drugs in food-producing animals.
    Donoho AL
    J Toxicol Environ Health; 1977 Mar; 2(4):909-12. PubMed ID: 853546
    [No Abstract]   [Full Text] [Related]  

  • 32. 1984 Stokinger lecture. Some questions and opinions on issues in toxicology and risk assessment.
    Weil CS
    Am Ind Hyg Assoc J; 1984 Oct; 45(10):663-70. PubMed ID: 6496314
    [No Abstract]   [Full Text] [Related]  

  • 33. The Food and Drug Administration Information Center on adverse reactions and hazards.
    Saiger GL
    Pharmakotherapia; 1965; 2(2):124-8. PubMed ID: 5875220
    [No Abstract]   [Full Text] [Related]  

  • 34. The control of drugs and therapeutic freedom.
    Dunlop D
    Proc R Soc Med; 1968 Aug; 61(8):841-6. PubMed ID: 5695368
    [No Abstract]   [Full Text] [Related]  

  • 35. Medication risk must be balanced with benefit, not fear.
    Jones KW
    Ann Pharmacother; 2010 Apr; 44(4):737-9. PubMed ID: 20332340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The FDA's classification system for new drugs. An evaluation of therapeutic gain.
    Finkel MJ
    N Engl J Med; 1980 Jan; 302(3):181-3. PubMed ID: 7350458
    [No Abstract]   [Full Text] [Related]  

  • 37. Adulteration of drugs and foods: compendial approaches to lowering risk.
    Abernethy DR; Sheehan C; Griffiths JC; Williams RL;
    Clin Pharmacol Ther; 2009 Apr; 85(4):444-7. PubMed ID: 18463621
    [No Abstract]   [Full Text] [Related]  

  • 38. Annual review of newly approved drugs.
    Kupecz D
    Nurse Pract; 1997 Jan; 22(1):136, 138, 140 passim. PubMed ID: 9004315
    [No Abstract]   [Full Text] [Related]  

  • 39. Keeping watch on drug quality.
    Furman WB
    FDA Consum; 1975 Oct; 9(8):18-23. PubMed ID: 10316632
    [No Abstract]   [Full Text] [Related]  

  • 40. Scientific basis for nonapproved use of drugs in veterinary practice.
    Brumbaugh GW
    J Am Vet Med Assoc; 1993 May; 202(10):1693-6;discussion 1713-7. PubMed ID: 8514586
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.